Price Chart

DATE TIME TYPE PERIOD REPORTED
EPS
ESTIMATED
EPS
SURPRISE
02/24/2023* -- Earnings Call Q4 2022 -- -- --
02/24/2023* -- Results Q4 2022 -- -0.23 --
10/31/2022 16:30 EST Earnings Call Q3 2022 -- -- --
10/31/2022 -- Results Q3 2022 -0.34 -0.47 27.92%
08/01/2022 -- Results Q2 2022 -0.47 -0.58 18.50%
08/01/2022 16:30 EST Earnings Call Q2 2022 -- -- --
05/05/2022 16:30 EST Earnings Call Q1 2022 -- -- --
05/05/2022 -- Results Q1 2022 -0.50 -0.67 25.37%
*Estimated Date/Time

Earnings

Next Report Date 02/24/2023 (est.)
EPS Estimate Upgrade
Last Actual EPS Upgrade

Loading chart...
Last Report Date 10/31/2022
Beat/Miss Upgrade
Return Since -3.83%
Last FQE 09/30/2022
Next FQE 12/30/2022

Profile

Edit
Axonics Inc is a United stated based medical technology company. It focuses on the design, development, and commercialization of innovative and minimally invasive sacral neuromodulation (SNM) solutions. SNM therapy is primarily used to treat patients with overactive bladder, fecal incontinence, and urinary retention. The company has designed and developed the r-SNM System, which delivers mild electrical pulses to the targeted sacral nerve in order to restore normal communication to and from the brain to reduce the symptoms of overactive bladder and fecal incontinence.
URL https://www.axonics.com
Investor Relations URL https://ir.axonics.com/
HQ State/Province California
Sector Healthcare
Industry Medical Devices
Equity Style Small Cap/Growth
Next Earnings Release Feb. 24, 2023 (est.)
Last Earnings Release Oct. 31, 2022
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Dividends

Dividend Per Share (TTM) --
2017
2018
2019
2020
2021
No data available
 
6.00%
4.00%
2.00%
 
Yield to Market 0.00
Yield to Sector 0.00
Yield to Industry 0.00
Last Dividend Amt. --
Dividend Frequency --
Last Ex-Dividend Date --
Yield (TTM) 0%
Forward Yield --
Payout Ratio 0.00%
Cash Payout Ratio 0.00%
Consistent Payer (5Y) No
Consistent Growth (5Y) No

Ownership

Insider Ownership Percentage Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Short Interest

Short Interest Upgrade
Percent of Shares Outstanding Short Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Total Returns Comparison

Edit comparables

Annual Total Returns Versus Peers

Edit comparables
Loading chart...
Name
2015
2016
2017
2018
2019
2020
2021
YTD
--
--
--
--
83.39%
80.15%
12.18%
25.61%
1.38%
11.96%
21.83%
-4.38%
31.49%
18.40%
28.71%
-13.26%
-20.56%
6.64%
175.2%
-43.60%
-44.14%
-28.92%
-61.70%
59.03%
--
--
--
--
--
113.0%
56.35%
-34.06%
12.54%
-0.61%
-55.33%
-55.16%
-65.37%
-71.39%
52.40%
40.37%
-67.80%
-28.59%
-49.84%
-47.69%
-93.17%
229.0%
-48.60%
-56.50%
As of December 02, 2022.

Profile

Edit
Axonics Inc is a United stated based medical technology company. It focuses on the design, development, and commercialization of innovative and minimally invasive sacral neuromodulation (SNM) solutions. SNM therapy is primarily used to treat patients with overactive bladder, fecal incontinence, and urinary retention. The company has designed and developed the r-SNM System, which delivers mild electrical pulses to the targeted sacral nerve in order to restore normal communication to and from the brain to reduce the symptoms of overactive bladder and fecal incontinence.
URL https://www.axonics.com
Investor Relations URL https://ir.axonics.com/
HQ State/Province California
Sector Healthcare
Industry Medical Devices
Equity Style Small Cap/Growth
Next Earnings Release Feb. 24, 2023 (est.)
Last Earnings Release Oct. 31, 2022
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Ownership

Insider Ownership Percentage Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Short Interest

Short Interest Upgrade
Percent of Shares Outstanding Short Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Top Fund Holders

Symbol Dollars Invested % Weight
NBDS 229941.0 USD 4.24%
BDFUX 44.94M USD 3.91%
IBRN 196671.0 USD 3.61%
CCRIX 50.38M USD 3.48%
FRTY 869723.0 USD 3.08%
LADQX 63.53M USD 2.57%
DIGGX 73.09M USD 2.18%
FDHT 212710.0 USD 2.13%
LCGRX 40.75M USD 2.05%
BSCUX 70.44M USD 1.79%
NSCS 83599.00 USD 1.49%
BTEC 505534.0 USD 0.87%

Top Portfolio Holders

0 of 0

Other Resources

Whale Wisdom 13F Filings
Seeking Alpha Call Transcripts
Nasdaq Insider Trading
Nasdaq Institutional Ownership
Nasdaq Option Chain
SEC SEC Filings
Twitter AXNX Tweets